Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled Phase 2 study of IDEA-070 (ketoprofen in Transfersome) in dermatological diseases
2004-002398-22Phase 2Completed
- Sponsor
- IDEA AG
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Dermatopathy comparing IDEA-070 with Placebo (2 arms). Primary endpoint: Investigator Global Assessment score (IGA). Started Sep 2004; status: completed.
02
Drugs
diractin
03
Conditions
Dermatopathy
Beyond the preview
Go deeper on 2004-002398-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002398-22.